Frazier Lifesciences Acquisition Corp

Frazier Lifesciences Acquisition Corp, trading under the ticker FLAC, is a blank-check company sponsored by an affiliate of Frazier Healthcare Partners, a life sciences-focused investment firm with a long track record in biopharmaceuticals and medical technology. The SPAC completed its initial public offering in 2021, targeting acquisition opportunities in the life sciences and healthcare sectors. In October 2022, the company filed a DEFM14A — a definitive merger proxy — with the SEC, signaling that a business combination agreement had been reached and shareholder approval was being sought. The filing, assigned accession number 0001193125-22-264485, placed FLAC in an advanced stage of its transaction process. Sign up for a free SpacDesk account to access the full filing history, deal timeline, and sponsor analytics for FLAC and hundreds of other SPACs.